About this item:

70 Views | 87 Downloads

Author Notes:

Address for correspondence: K. Sharma, MD, Department of Emergency Medicine, University of Texas Health Science Center Houston, 6431 Fannin Street, JJL 435, Houston, TX 77030. (Email: sharmakm@gmail.com)

The authors acknowledge the contributions of the field data collectors from the Madras Diabetes Research Foundation: Duraivel, Ilangovan, Karthik, and Kumar.

A portion of these data were previously presented in the abstract format at the World Diabetes Federation Conference in Dubai on December 6, 2011.

The authors have no conflicts of interest relevant to this article.

The authors assert that this manuscript is original research.

No competing financial interests exist.

Subjects:

Research Funding:

KS was funded through a fellowship provided by Vanderbilt University School of Medicine.

This study was enabled in part by the Emory Global Health Institute's financial support of the Global Diabetes Research Center (GDRC).

Keywords:

  • Costs
  • India
  • diabetes
  • direct cost
  • economics
  • indirect cost

Excess cost burden of diabetes in Southern India: a clinic-based, comparative cost-of-illness study.

Journal Title:

Global Health, Epidemiology and Genomics

Volume:

Volume 1

Publisher:

, Pages e8-e8

Type of Work:

Article | Final Publisher PDF

Abstract:

Background: There are few data on excess direct and indirect costs of diabetes in India and limited data on rural costs of diabetes. We aimed to further explore these aspects of diabetes burdens using a clinic-based, comparative cost-of-illness study. Methods: Persons with diabetes (n = 606) were recruited from government, private, and rural clinics and compared to persons without diabetes matched for age, sex, and socioeconomic status (n = 356). We used interviewer-administered questionnaires to estimate direct costs (outpatient, inpatient, medication, laboratory, and procedures) and indirect costs [absence from (absenteeism) or low productivity at (presenteeism) work]. Excess costs were calculated as the difference between costs reported by persons with and without diabetes and compared across settings. Regression analyses were used to separately identify factors associated with total direct and indirect costs. Results: Annual excess direct costs were highest amongst private clinic attendees (INR 19 552, US$425) and lowest amongst government clinic attendees (INR 1204, US$26.17). Private clinic attendees had the lowest excess absenteeism (2.36 work days/year) and highest presenteeism (0.06 work days/year) due to diabetes. Government clinic attendees reported the highest absenteeism (7.48 work days/year) and lowest presenteeism (-0.31 work days/year). Ten additional years of diabetes duration was associated with 11% higher direct costs (p < 0.001). Older age (p = 0.02) and longer duration of diabetes (p < 0.001) were associated with higher total lost work days. Conclusions: Excess health expenditures and lost productivity amongst individuals with diabetes are substantial and different across care settings. Innovative solutions are needed to cope with diabetes and its associated cost burdens in India.

Copyright information:

© The Author(s) 2016

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote